IPO registrations (S-1, F-1) · Registrants

GENAERA CORP

SEC CIK
880431 · filings on EDGAR ↗
Name on the registration
MAGAININ PHARMACEUTICALS INC
Former names
MAGAININ PHARMACEUTICALS INC (1994–2001)
Registration
Form S-1, first filed 1999-09-28, last 1999-10-13; 1 initial registration, 1 amendment
Outcome
Final prospectus filed 1999-10-18
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
5110 CAMPUS DR, Plymouth Meeting, PA 19462
EIN
13-3445668
EDGAR entity type
operating
Insiders and CEO pay
GENAERA CORP on the corporate pages

Offering terms

Final price
$1.00 per share (424B1 filed 1999-10-18)
Shares sold
4,000,000
Gross proceeds
$4,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MAGN

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 3

FiledFormWhat it isName as filedEDGAR
1999-09-28S-1S-1 (registration)MAGAININ PHARMACEUTICALS INC0001036050-99-001972 ↗
1999-10-13S-1/AS-1/A (amendment)MAGAININ PHARMACEUTICALS INC0001036050-99-002061 ↗
1999-10-18424B1424B1 (final prospectus)MAGAININ PHARMACEUTICALS INC0001036050-99-002107 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1999-10-13S-1/Aregistration statement4,000,000-Nasdaq MAGN0from the submission text; shares headlinedocument ↗
1999-10-18424B1final prospectus$1.004,000,000$4,000,000Nasdaq MAGN0from the submission text; price sentence, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ARMSTRONG JOHN L JRDirector,Officer; OfficerCEO; President and CEO; President & CEO202006–2008
IMASOGIE OSAGIE ODirector62006–2008person page Fuzzy
ECOCK R FRANKDirector72006–2008
LEVITT ROY CDirector32006
Gast Michael JOfficerChief Medical Officer; EVP & Chief Medical Officer; EVP Clinical and Development; EVP Clinical and Research; Executive VP of Clin Research; SVP Clinical/ Development72006–2008
SAVINO PETER JDirector42006–2007
SKOLAS JOHN AOfficerEVP, CFO and General Counsel; EVP, CFO & General Counsel22006
HOROVITZ ZOLA PDirector42006–2008
SHAPIRO ROBERT FDirector52006–2008
WYNGAARDEN JAMES BDirector22006–2007
Kelly Leanne M.OfficerSr. Vice President & CFO; Sr. VP and CFO; SVP & CFO; SVP & Chief Financial Officer62007–2008
Xmark Opportunity Partners, LLCTenPercentOwner402007–2009
Wolfe Henry ROfficerEVP & Chief Scientific Officer32007–2008
Kaye Mitchell DDirector,TenPercentOwner142007–2009
Wotton Paul KDirector32008

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerGENAERA CORPSEC filers (EDGAR)CIK (EXACT)
Business registrationGenaera CorporationState business registriesname and state
Person pageOsagie O ImasogiePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Biological Products, (No Diagnostic Substances) · Health